SYSTEMATIC LITERATURE REVIEW OF REAL-WORLD EVIDENCE ON ADHERENCE WITH BIOLOGICS IN INFLAMMATORY BOWEL DISEASE IN THE UNITED STATES

被引：0
|
作者：
Rupniewska, E. [1 ]
Singer, D. [2 ]
Khan, S. [3 ]
Neighbors, M. [3 ]
Chiarappa, J. A. [2 ]
Obando, C. A. [4 ]
机构：
[1] RTI Hlth Solut, Manchester, Lancs, England
[2] Janssen Sci Affairs, Titusville, NJ USA
[3] RTI Hlth Solut, Durham, NC USA
[4] Janssen Sci Affairs, Horsham, PA USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PGI34
引用
收藏
页码：S87 / S87
页数：1
相关论文
共 50 条
  • [1] SYSTEMATIC LITERATURE REVIEW OF REAL-WORLD EVIDENCE ON PERSISTENCE, SWITCHING, AND DOSE ESCALATION WITH BIOLOGICS IN INFLAMMATORY BOWEL DISEASE IN THE UNITED STATES
    Rupniewska, E.
    Singer, D.
    Khan, S.
    Neighbors, M.
    Chiarappa, J. A.
    Obando, C. A.
    VALUE IN HEALTH, 2018, 21 : S87 - S88
  • [2] Real-world evidence on adherence, persistence, switching and dose escalation with biologics in adult inflammatory bowel disease in the United States: A systematic review
    Khan, Shahnaz
    Rupniewska, Ewa
    Neighbors, Mackenzie
    Singer, David
    Chiarappa, Joseph
    Obando, Camilo
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2019, 44 (04) : 495 - 507
  • [3] Real-world Adherence to Biologics and Association With Health Outcomes in Patients With Asthma: A Systematic Literature Review
    Cristancho, R. Alfonso
    Wittkopf, P.
    Martin, A.
    Park, J.
    Pande, A.
    Benson, V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [4] Real-World Effectiveness of Vedolizumab Dose Escalation in Patients With Inflammatory Bowel Disease: A Systematic Literature Review
    Patel, Dipen
    Martin, Stephan
    Luo, Michelle
    Ursos, Lyann
    Lirio, Richard A.
    Kamble, Pravin
    Wang, Song
    CROHNS & COLITIS 360, 2022, 4 (03)
  • [5] Dose escalation and switching of biologics in ulcerative colitis: a systematic literature review in real-world evidence
    Gemayel, Nathalie C.
    Rizzello, Eugenio
    Atanasov, Petar
    Wirth, Daniel
    Borsi, Andras
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (11) : 1911 - 1923
  • [6] Real-World Persistency for Inflammatory Bowel Disease Biologics Using Patient Registry Data
    Goss Sawhney, Tia
    Dobes, Angela
    O'Charoen, Sirimon
    CROHNS & COLITIS 360, 2023, 5 (04)
  • [7] CHARACTERISTICS OF REAL-WORLD DATABASES IN THE UNITED STATES: A SYSTEMATIC REVIEW
    Raval, N.
    Raval, A.
    VALUE IN HEALTH, 2024, 27 (06) : S369 - S369
  • [8] A Narrative Systematic Review and Categorisation of Outcomes in Inflammatory Bowel Disease to Inform a Core Outcome Set for Real-world Evidence
    Wong, Charlotte
    van Oostrom, Joep
    Bossuyt, Peter
    Pittet, Valerie
    Hanzel, Jurij
    Samaan, Mark
    Tripathi, Monika
    Czuber-Dochan, Wladyslawa
    Burisch, Johan
    Leone, Salvatore
    Saldana, Roberto
    Baert, Filip
    Kopylov, Uri
    Jaghult, Susanna
    Adamina, Michel
    Gecse, Krisztina
    Arebi, Naila
    JOURNAL OF CROHNS & COLITIS, 2022, 16 (10): : 1511 - 1522
  • [9] Real-world subcutaneous infliximab for inflammatory bowel disease: A systematic review and meta-analysis
    Chetwood, J.
    Tran, Y.
    Subramanian, S.
    Smith, P.
    Iborra Colomino, M.
    Buisson, A.
    Paramsothy, S.
    Leong, R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 160 - 161
  • [10] Trends in the Utilization of Biologics for Inflammatory Bowel Disease in the United States
    Chen, Chao
    Hartzema, Abraham
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 274 - 274
12345